Carregando...

Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges

To improve quality of life and prevent long-term risks in patients with inflammatory bowel diseases (IBDs: Crohn’s disease, ulcerative colitis), it is essential to suppress inflammatory activity adequately. However, corticosteroids are only suitable for therapy of acute flares and the evidence for p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Principais autores: Vetter, Marcel, Neurath, Markus F.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5638182/
https://ncbi.nlm.nih.gov/pubmed/29051788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17727388
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!